PATENT CLAIM ANALYSIS

Application Number: 16155867
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-03
Patent Classification: ["514", "222500"]

Abstract:
The present invention relates to a heterocyclic-substituted pyridinopyrimidinone derivative and the use thereof as a therapeutically effective cyclin-dependent kinase (CDK) inhibitor. In particular, the present invention relates to the use of a new heterocyclic-substitute pyridinopyrimidinone derivative as shown in formula (I) and a pharmaceutical composition thereof as a selective CDK4/6 inhibitor in preventing or treating diseases related to CDK4/6.

Claim (Index 7):
A pharmaceutical composition comprising a therapeutically effective amount of the heterocyclic-substituted pyridinopyrimidinone derivative according to any of  claim 1  and a pharmaceutically acceptable carrier or excipient.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16155861', '14010819', '11245314', '13773052', '13547314']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7327401752642559
- 35 USC 102 Novelty (BERT): 0.5156668979272779
- Combined Prediction Score: 0.7110328475305582
- Mean Citation Score: 266.201076
- Max Citation Score: 297.04935
- Similarity Product: 237.24388908568025

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test